Roles of microRNA-29 a in the Antifibrotic Effect of Farnesoid X Receptor in Hepatic Stellate Cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of nuclear receptor SHP in metabolism and cancer.

  2011cited by this paper
• Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis

  2011influential reference
• miR-29 is a major regulator of genes associated with pulmonary fibrosis.

  2011cited by this paper
• MicroRNAs and the regulation of fibrosis

  2010cited by this paper
• microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia

  2010cited by this paper
• Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.

  2010cited by this paper
• Transcriptional suppression of mir‐29b‐1/mir‐29a promoter by c‐Myc, hedgehog, and NF‐kappaB

  2010cited by this paper
• Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice

  2010cited by this paper
• Thyroid Hormone May Regulate mRNA Abundance in Liver by Acting on MicroRNAs

  2010cited by this paper
• miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop*

  2010cited by this paper
• Cellular microRNA and P bodies modulate host-HIV-1 interactions.

  2009cited by this paper
• Small silencing RNAs: an expanding universe

  2009influential reference
• Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance

  2009cited by this paper
• miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis.

  2009cited by this paper
• Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine

  2009cited by this paper
• Hepatic fibrosis

  2009cited by this paper
• Over‐expressed microRNA‐27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation

  2009cited by this paper
• 280 MICRORNA-29: A NOVEL ANTIFIBROGENIC MEDIATOR IN LIVER FIBROGENESIS

  2009cited by this paper
• Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: insights from evidence on hepatic cholesterol degradation and gallstone disease in humans.

  2008cited by this paper
• Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

  2008cited by this paper
• A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence

  2008cited by this paper
• FXR-mediated regulation of eNOS expression in vascular endothelial cells.

  2008cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• Molecular mechanisms of hepatic fibrogenesis

  2007cited by this paper
• Downregulation of Endothelin-1 by Farnesoid X Receptor in Vascular Endothelial Cells

  2006cited by this paper
• Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms.

  2005cited by this paper
• Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis

  2005cited by this paper
• A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis

  2005cited by this paper
• Normal rat hepatic stellate cells respond to endotoxin in LBP‐independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes

  2005cited by this paper
• Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis

  2004cited by this paper
• The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis.

  2004influential reference
• Prediction of mammalian microRNA targets.

  2003cited by this paper
• A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.

  2003influential reference
• Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.

  2002cited by this paper
• Bile acid regulation of gene expression: roles of nuclear hormone receptors.

  2002cited by this paper
• Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

  2002cited by this paper
• Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

  2000cited by this paper
• Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation*

  2000cited by this paper
• Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor*

  2000cited by this paper
• Identification of a chemical tool for the orphan nuclear receptor FXR.

  2000influential reference
• Identification of a nuclear receptor that is activated by farnesol metabolites.

  1995cited by this paper
• The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

  1993cited by this paper
• Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.

  1991cited by this paper

• on the pharmacological effects of Astragaloside IV Running head : review of Astragaloside IV

  2016cites this paper
• MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis

  2013cites this paper
• MicroRNA changes associated with atypical CYP1A1 inducer BMS-764459.

  2013cites this paper